Multicenter Retrospective Study to Evaluate Compliance to Therapy and Drug Survival of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis in Routine Daily Clinical Practice
Phase of Trial: Phase IV
Latest Information Update: 01 Jul 2013
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms REMISSION II
- Sponsors Roche
- 23 May 2013 Planned end date changed from 1 Oct 2013 to 1 May 2013 as reported by ClinicalTrials.gov.
- 01 May 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Aug 2012 New trial record